Renaissance Technologies - AEVI GENOMIC MEDICINE INC ownership

AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 39 filers reported holding AEVI GENOMIC MEDICINE INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of AEVI GENOMIC MEDICINE INC
ValueSharesWeighting
Q4 2019$382,000
+6.4%
2,615,632
+9.4%
0.00%
Q3 2019$359,000
+14.7%
2,391,788
+22.3%
0.00%
Q2 2019$313,000
+46.3%
1,955,391
+79.1%
0.00%
Q1 2019$214,000
+375.6%
1,091,917
+1583.1%
0.00%
Q4 2018$45,000
+28.6%
64,877
+125.5%
0.00%
Q3 2018$35,000
-74.3%
28,770
-63.4%
0.00%
Q2 2018$136,000
+25.9%
78,570
+46.3%
0.00%
Q1 2018$108,000
-3.6%
53,700
-42.6%
0.00%
Q4 2017$112,000
+489.5%
93,600
+515.8%
0.00%
Q3 2017$19,00015,2000.00%
Other shareholders
AEVI GENOMIC MEDICINE INC shareholders Q4 2018
NameSharesValueWeighting ↓
22NW, LP 155,000$206,0000.12%
Birchview Capital, LP 128,000$170,0000.09%
CARL DOMINO INC 43,273$58,0000.07%
NORTHERN CAPITAL MANAGEMENT LLC 106,050$141,0000.05%
ELEMENT CAPITAL MANAGEMENT LLC 124,423$165,0000.03%
Baker Brothers Advisors 1,618,089$2,152,0000.02%
SIMON QUICK ADVISORS, LLC 24,390$32,0000.02%
ARTHUR M. COHEN & ASSOCIATES, LLC 31,390$42,0000.02%
WHITE PINE CAPITAL LLC 20,000$27,0000.01%
LMR Partners LLP 112,265$149,0000.01%
View complete list of AEVI GENOMIC MEDICINE INC shareholders